*Corresponding author. Tel: +33-1-45-21-36-32; Fax: +33-1-45-21-63-40; E-mail: nordmann.patrice@bct.ap-hop-paris.fr Sir, At the beginning of the 1990s, extended-spectrum β-lactamase (ESBL)-producing Gram-negative bacteria, exhibiting a higher level of resistance to cefotaxime than to ceftazidime, were described in Germany (1990), France and Argentina (1992). 1 These ESBLs were named CTX-M type β-lactamases, owing to their high level of activity against cefotaxime. 1 Such Ambler class A β-lactamases have <40% identity with the β-lactamases of the TEM and SHV series. 1 Twenty-nine different genes encoding CTX-Ms have been characterized so far. They have been identified mostly from Enterobacteriaceae isolated from various geographical areas, mainly from South America, Europe and East Asia. 1 Unlike most CTX-Ms, CTX-M-15, CTX-M-16 and CTX-M-19 hydrolyse ceftazidime at a higher rate than cefotaxime. 2 We report here the first detection of a clinical isolate from Turkey that expresses CTX-M-15.
In September 2001, a multiresistant isolate of Klebsiella pneumoniae (KP7881) was isolated from a urine sample of a patient hospitalized in the surgical unit of the Istanbul Faculty Hospital. This isolate was resistant to all β-lactams except imipenem. MICs of β-lactams were determined by an agar dilution method (Table 1) . 2 A ceftazidime/co-amoxiclav synergy test was slightly positive, whereas a cefotaxime/co-amoxiclav synergy test remained negative. The isoelectric points (pI) 2 of culture extracts of this isolate were 5.6, 6.1, 7.4, 8.2 and 8.6. Plasmid DNA was isolated by the Kieser procedure 3 and transformed into Escherichia coli DH10B by electroporation as described. 2 Four antibiotic resistance phenotypes of transformants were obtained: three gave different ESBL phenotypes and another exhibited resistance to penicillins and co-amoxiclav. The MICs of β-lactams for the four transformants and the parental isolate are shown in Table 1 . Transformant 1 was resistant to cefotaxime and of intermediate susceptibility to ceftazidime. It was also resistant to kanamycin, tobramycin, amikacin, netilmicin, spectinomycin, tetracycline, sulphonamides, trimethoprim and chloramphenicol. PCR amplification, performed with DNA of transformant 1 as template using bla CTX-M -specific primers, 2 was positive, and sequencing of the PCR product identified the bla CTX-M-15 gene. Using PCR experiments, an insertion sequence ISEcp1 was identified upstream of the 5′ end of this gene, with primers hybridizing to the ends of this insertion sequence. 2 The pI value of this ESBL was 8.6, and the bla CTX-M-15 gene was located on a 60 kb plasmid. Two other transformants (transformants 2 and 3) exhibited an ESBL phenotype with a higher resistance to ceftazidime than to cefotaxime. Using primers specific for the SHV gene, 2 bla SHV-12 (pI 8.2) was identified in transformant 2 located on a 70 kb plasmid, and in transformant 3 on a 190 kb plasmid. In addition, in transformant 3, three other β-lactamase genes were identified [bla TEM-2 (pI 5.4), bla OXA-1 (pI 7.4) and bla OXA-10 (pI 6.1)] also using primers specific for the TEM gene, 2 the OXA-1 gene 2 and the OXA-10 gene. 2 Transformant 4, exhibiting a restricted spectrum β-lactamase phenotype, encoded two β-lactamases that corresponded to TEM-2 and OXA-10, and was located on a 140 kb plasmid.
K. pneumoniae KP7881 was resistant to cefoxitin and moxalactam, which was not explained by any of the ESBLs identified. However, culture extracts of that isolate did not hydrolyse these β-lactams (data not shown). In a disc diffusion test on Mueller-Hinton agar containing cloxacillin 250 mg/L, 2 the presence of cloxacillin did not inhibit the cephalosporinase activity, which confirmed the absence of a plasmid-mediated cephalosporinase. Thus, the outer membrane protein profile was studied by sodium dodecyl sulphatepolyacrylamide gel electrophoresis analysis. A major ~35 kDa outer membrane protein of K. pneumoniae was lacking (data not shown), 4 suggesting that cefoxitin and moxalactam resistance could have been related to a permeability defect.
β-Lactamase CTX-M-15, which differs from CTX-M-3 by a single amino acid substitution Asp-240 to Gly, was identified first in India 2 and in Japan (GenBank accession no. AY013478), and was subsequently detected in Canada, Russia, Bulgaria, Poland 5 and France. 6 Its report now in Turkey suggests that the bla CTX-M-15 gene may be highly prevalent worldwide. Moreover, as found previously in India 2 and Poland, 5 K. pneumoniae KP7881 also possesses ISEcp1 located upstream of the bla CTX-M-15 gene. The ISEcp1 element was located at exactly the same position upstream of bla CTX-M-15 as found in Indian isolates, but closer to the bla CTX-M-15 gene, as opposed to what was reported from Polish isolates. 5 Thus, an identical bla CTX-M-15 gene may be spreading in Poland and Turkey but located on different genetic backgrounds. The ability of the ISEcp1 element to mobilize and promote expression of β-lactamase genes may explain, in part, the current spread of the bla CTX-M-15 gene.
